Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Takeda hands back rights to two Amgen drugs

Returns pain and ovarian cancer candidates but will continue with collaboration

Sanofi reception

Sanofi and Boehringer agree asset swap deal

Will exchange Merial animal health business for consumer healthcare unit in $25bn deal

- PMLiVE

Cello Health Insight bolsters senior team

Maria Eletskaya joins the agency as a director

- PMLiVE

Digital doctors: Talk in 2016

The evolving relationship between patient, physician and pharma

Syneos Health®

- PMLiVE

Tracking comms trends: tackling reputational issues head on

From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today

- PMLiVE

Digital doctors: Talk in 2016

The evolving relationship between patient, physician and pharma

- PMLiVE

UCB joins with Atlético Madrid for epilepsy awareness campaign

Spanish football players release video in support of ongoing initiative

- PMLiVE

UK pharma faces ‘immediate challenges’ following Brexit

Life science sector awaits fallout from vote to leave the European Union

Gilead Sciences

Gilead gets EU nod for TAF-based triple therapy for HIV

Once-daily, single-tablet Odefsey reduces risks of side effects such as renal and bone toxicity

Celgene building

NICE rejects Celgene’s Vidaza for leukaemia

Final draft guidance cites ‘high degree of uncertainty’ over clinical efficacy

- PMLiVE

Minoyrx Therapeutics appoints chief medical officer

Dr Uwe Meya joins from Lupin Atlantis Holdings

- PMLiVE

Christian Schade joins Aprea AB

He takes up the role of president and chief executive officer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links